Syndax Pharmaceuticals (SNDX) Total Debt Growth (3y) (2024)

Syndax Pharmaceuticals (SNDX) Total Debt Growth (3y) (2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 50.25%
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 25.25%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.07%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Syndax Pharmaceuticals 1.87 Bn 1.52 Bn 53.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 158.51%